Pfizer raises prices on 91 drugs in second round of increases this year

Pfizer raises prices on 91 drugs in second round of increases this year While other leading drug companies are pledging to hold their price increases to single digits and releasing pricing transparency reports to the public, on June 1 Pfizer unabashedly raised the wholesale price on 91 of its drugs—the...

Read more

Lawsuit claims Novo Nordisk and OptumRx conspired to inflate price of diabetes drug Victoza

Top Stories in Business & Health for June 5, 2017 Lawsuit claims Novo Nordisk and OptumRx conspired to inflate price of diabetes drug Victoza Another diabetes drug-related proposed class action lawsuit was filed last week in a California district court. This one contends that Novo Nordisk raised the price of...

Read more

Steward Health Care merger will create largest private for-profit hospital operator in US

Top Stories in Business & Health for May 22, 2017 Steward Health Care merger will create largest private for-profit hospital operator in US On Friday, Boston-based Steward Health Care announced a definitive agreement to merge with Franklin, Tenn.-based IASIS Healthcare LLC. If the proposed transaction is successful, the combined entity...

Read more

Anthem terminates merger agreement with Cigna

Top Stories in Business & Health for May 15, 2017 Anthem terminates merger agreement with Cigna  Anthem announced Friday that it would no longer pursue its merger with Cigna. “Cigna has failed to perform and comply in all material respects with its contractual obligations,” Anthem said in a press release....

Read more

Harvard Pilgrim signs outcomes-based refund contract with Amgen for Repatha

Top Stories in Business & Health for May 8, 2017 Harvard Pilgrim signs outcomes-based refund contract with Amgen for Repatha _________ Amgen and Harvard Pilgrim executed a “first-of-its-kind” contract under which the health plan can receive a full rebate for the cost of Repatha (evolocumab) if an eligible patient experiences...

Read more